Shanghai Pharma expands reach

Updated 2017-11-16 10:33:11 China Daily
A booth of Shanghai Pharmaceutical Holding Co at an exhibition of pharmaceutical and medical products held in Shanghai. The company is buying Cardinal Health Inc's drug distribution business in China.(Jing Wei/For China Daily)

A booth of Shanghai Pharmaceutical Holding Co at an exhibition of pharmaceutical and medical products held in Shanghai. The company is buying Cardinal Health Inc's drug distribution business in China.(Jing Wei/For China Daily)

Chinese firm buys drug distribution unit of U.S.-based Cardinal Health

The mainland's third-largest drug distributor Shanghai Pharmaceutical Holding Co is buying U.S.-based Cardinal Health Inc's China drug distribution business for 7 million, to expand its presence nationwide.

The State-owned firm said in a regulatory statement that it will buy the pharmaceutical and medical products distribution business of Cardinal Health in China for a base payment of .2 billion.

However, the final acquisition price would be 7 million, taking into account the estimated adjustments related to working capital and shareholder loans.

The deal will also help Shanghai Pharma become a leading importer of foreign medicines into China, the world's second-largest drug market. The 7 acquisition price is 28 times Cardinal Health's net income for the financial year that ended in June.

The valuation was made based on the acknowledgement that Cardinal Health's business would help Shanghai Pharma's strategic expansion, particularly in regions that Shanghai Pharma is yet to fulfill market potential, such as Tianjin and Guizhou province.

The deal is yet to be approved by the Ministry of Commerce which will happen only after anti-monopoly examinations.

Cardinal Health is the eighth largest player in China's pharmaceutical and medical product distribution sector.

Shanghai Pharma is listed in both Shanghai and Hong Kong. Its HK-listed shares rose 0.62 percent to HK.34 (.48), while the Shanghai-listed shares rose 2.53 percent to 24.7 yuan (.72) on Wednesday.

"The purchase will enable Shanghai Pharma to consolidate and expand its distribution of drugs across China," said Zhou Jun, president of Shanghai Pharma.

Shanghai Pharma plans to build up a new direct-to-pharmacy (DTP) chain that combines its own existing outlets with Cardinal China's nationwide networks for imported drug distribution, he said.

Cardinal China set up its first DTP outlet in Shanghai at the end of 2012, and has since then been expanding across China with some 30 stores, with annual sales revenue of some 700 million yuan, serving about 200,000 customers. A single outlet's annual sales revenue of Cardinal China was more than 20 million yuan, which is about 40 times an average pharmacy's revenue, according to a report by Healthcare Executive, a pharmaceutical journal.

Also in the News

Nicole Kidman Recalls Oscar Glory: Loneliest Time
Showbiz2016/06/16 13:58December 11 2017 12:03:43

Nicole Kidman Recalls Oscar Glory: Loneliest Time

Attending Shanghai International Film Festival, Nicole Kidman talks about her role in "Grace of Monaco".

Labor Day Travel Peak Starts
Also in the News2014/05/01 12:16December 11 2017 12:03:43

Labor Day Travel Peak Starts

Johnny Depp Delivers a Speech 'Evolve the Future' in 'Transcendence'
Also in the News2014/04/18 13:18December 11 2017 12:03:43

Johnny Depp Delivers a Speech 'Evolve the Future' in 'Transcendence'

Hollywood star Johnny Depp's speech in the upcoming new film "Transcendence" has been disclosed on Friday, April 11th.

Most Watched

News:
China World Business Sports Showbiz Audio
Video:
C4 My Chinese Life The Sound Stage China Revealed Showbiz Video Travel Video
Photos:
China World Fun Travel Entertainment Sports
Travel:
Beijing Shanghai Guangzhou
Lifestyle:
Live Music Opera & Classical Movies Traditional Shows Exhibitions
Learn Chinese:
Chinese Studio Living Chinese Everyday Chinese Just For Fun Chinese Culture Buzzwords